Skelaxin Generics May Launch Before July 2005: FDA To Allow Labeling "Carve Out"

The agency says ANDA filers Eon and Corepharma may delete protected labeling on food effects covered by King’s method-of-use patent.

More from Archive

More from Pink Sheet